SCHEMBL1997224

SCHEMBL1997224

CC(C(=O)O)N(C)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.52
ADAMTS4 O75173 2/20 0.50
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
CYP2C19 P33261 1/20 0.47
FASN P49327 1/20 0.44
ALDH1A1 P00352 2/20 0.43
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8726244 1.00 PTGS2 (0.52) PTGS2ADAMTS4CYP1A2GAACYP2C9
SCHEMBL755703 0.88 ALDH1A1 (0.43) PTGS2ADAMTS4ALDH1A1KDM4ESMN1; SMN2
SCHEMBL755702 0.88 ALDH1A1 (0.43) PTGS2ADAMTS4ALDH1A1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL8226909 0.86 ALDH1A1 (0.42) PTGS2ADAMTS4ALDH1A1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL32662705 0.86 ALDH1A1 (0.42) PTGS2ADAMTS4ALDH1A1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL8226911 0.86 ALDH1A1 (0.42) PTGS2ADAMTS4ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10351875 0.84 PTGS2 (0.43) PTGS2ADAMTS4CYP1A2GAACYP2C9
SCHEMBL14969086 0.82 ADAMTS4 (0.59) PTGS2ADAMTS4CYP1A2GAACYP2C9
SCHEMBL8605929 0.81 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL31370844 0.81 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373627-A1 1- (BIPHENYL-4-YLMETHYL) IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES AND THEIR USE AS CB2 RECEPTOR AGONISTS N.V. Organon (NL) 2011-10-12 EP disclosed
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed
WO-2010063721-A1 1- (BIPHENYL-4-YLMETHYL) IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES AND THEIR USE AS CB2 RECEPTOR AGONISTS N.V. ORGANON (NL) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 PTGS2 2357/4885ADAMTS4 4515/4885CYP1A2 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.